Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
10,694
datasets available to search
ShareScore release 0.9.0
Dataset results
10,694 results for “carcinoma,”
A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Bili
ClinicalTrials.gov study NCT04338685. IPD Sharing: NO. Countries: 6. Publications: 0.
The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT00397540. IPD Sharing: Not stated. Countries: 1. Publications: 2.
RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib
ClinicalTrials.gov study NCT00410124. IPD Sharing: Not stated. Countries: 10. Publications: 7.
A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment
ClinicalTrials.gov study NCT04338269. IPD Sharing: YES. Countries: 15. Publications: 2.
A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT02521870. IPD Sharing: YES. Countries: 4. Publications: 1.
Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma
ClinicalTrials.gov study NCT02364076. IPD Sharing: Not stated. Countries: 1. Publications: 2.
CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT03428217. IPD Sharing: NO. Countries: 8. Publications: 1.
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
ClinicalTrials.gov study NCT03765918. IPD Sharing: YES. Countries: 24. Publications: 1.
Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT00946153. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC)
ClinicalTrials.gov study NCT03682055. IPD Sharing: NO. Countries: 5. Publications: 3.
A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT03141177. IPD Sharing: Not stated. Countries: 18. Publications: 13.
Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT02296684. IPD Sharing: NO. Countries: 1. Publications: 1.
Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02658019. IPD Sharing: NO. Countries: 1. Publications: 2.
Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00084682. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma
ClinicalTrials.gov study NCT02729194. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma
ClinicalTrials.gov study NCT03967977. IPD Sharing: YES. Countries: 2. Publications: 0.
A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma
ClinicalTrials.gov study NCT00044512. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site
ClinicalTrials.gov study NCT00193609. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract
ClinicalTrials.gov study NCT02928406. IPD Sharing: Not stated. Countries: 32. Publications: 6.
Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China E
ClinicalTrials.gov study NCT04924062. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.